| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |